Navigation Links
AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/6/2012

30, 2012 and $35.8 million at December 31, 2011.

"We continue to make progress in the execution of our Phase 3 program for ARX-01.  During the third quarter, we initiated our third Phase 3 clinical trial, received four additional U.S. patents related to our sufentanil NanoTab technology and we were notified that ARX-01 was deemed sufficiently novel that we would be allowed to use the centralized filing procedure for ARX-01 in Europe," stated Richard King, president and CEO of AcelRx. "In addition, we completed treatment of the final subject in our Phase 3 clinical trial comparing ARX-01 to IV PCA with morphine.  We expect to announce top line data from this first trial later this month and results from our two other ARX-01 trials is expected in the first quarter of 2013."

Review of Third Quarter Accomplishments and Corporate Update

  • In August 2012, AcelRx initiated the third of three planned Phase 3 clinical trials for ARX-01, a double-blind, placebo-controlled efficacy and safety trial in adult patients with post-operative pain following hip or knee replacement surgery.  This study is designed to enroll approximately 400 patients and is being conducted at approximately 45 academic and community hospitals in the U.S.  The primary endpoint is the sum of the pain intensity difference to baseline, over the 48 hour study period, or SPID-48, which is the FDA standard for post-operative acute pain studies.
  • Dosing of the last patient in the Phase 3 open label, active comparator study comparing efficacy and safety of the Sufentanil NanoTab System to the commonly used IV PCA with morphine is complete, and top line data are expected in November, 2012.  Top line results from the two placebo-controlled Phase 3 clinical studies, one treating post-operative pain in patients following abdominal surgery and the other treating post-operative pain in patients following hip or knee replacement, are both expected during the fir
    '/>"/>

  • SOURCE AcelRx Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
    2. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
    3. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
    4. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    5. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
    6. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
    7. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
    8. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
    9. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
    10. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
    11. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
    (Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
    (Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
    Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
    ... Sept. 17 Henry Schein, Inc., (Nasdaq: HSIC ... to office-based practitioners, announced today that Steven Paladino, Henry Schein,s ... the UBS Global Life Sciences Conference at the Grand Hyatt ... begin at 9 a.m. EDT and can be heard via ...
    ... BIOD ) announced today the appointment of Arthur ... chairman of ArcherGroup, a private investment and consulting services firm, ... Kroll Bond Rating Agency.  He is a retired chairman of ... spent 30 years at Merrill Lynch & Company where he ...
    Cached Medicine Technology:Henry Schein to Present at the UBS Global Life Sciences Conference 2Biodel Appoints Arthur Urciuoli to its Board of Directors 2Biodel Appoints Arthur Urciuoli to its Board of Directors 3
    (Date:4/17/2014)... chronic inflammation in benign prostate tissue was associated ... association was found even in those with low ... published in Cancer Epidemiology, Biomarkers & Prevention ... Cancer Research. , An analysis of prostate tissue ... arm of the Prostate Cancer Prevention Trial (PCPT) ...
    (Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
    (Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
    (Date:4/17/2014)... YORK, NY (April 16, 2014) The cause of ... a new study proposes that neurons may be mistaken ... immune system, similar to the way autoimmune diseases like ... the body,s cells. The study was published April 16, ... a new, and likely controversial, idea in Parkinson,s disease; ...
    (Date:4/17/2014)... led by researchers at UC Davis has shown that ... role in cell division, also boosts the mitochondrial activity ... the complex has been shown to perform both jobs. ... target to control cellular energy production, potentially advancing cancer ... today in the journal Developmental Cell . , ...
    Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
    ... consistent association, , FRIDAY, May 14 (HealthDay News) -- Babies ... to bear a higher risk for infant death, brain damage ... , The finding, reported online May 14 in BMJ ... Birmingham Women,s Hospital in England. , The authors note that ...
    ... Inappropriate ... ... -- A guide to BRCA1 and BRCA2 genetic testing has been released by Hayes, ... are not trained in genetics with independent, evidence-based information to help them understand the ...
    ... ... East Coast Distribution Center serves as a fulfillment center established to expedite the transit ... , ... (Vocus) May 14, 2010-- Swanson Health Products (SHP) is proud to announce an ...
    ... ... obesity can consider a new primary weight loss operation known as the Laparoscopic Sleeve Gastrectomy ... offering the surgery for $11,000. Read for more details. , ... (PRWEB) May 14, 2010 -- People who suffer from morbid ...
    ... ... , ... NY (Vocus) May 13, 2010 -- Mount Sinai School of Medicine at its 41st ... and human genome research, and renowned humanists whose work has advanced biomedical research and ...
    ... Michigan survey, most said they,d try to get to ER on ... aren,t familiar with the symptoms of a stroke and most who ... stroke occurred, a new survey finds. , "If you know the ... them, that doesn,t do you much good," said study author Chris ...
    Cached Medicine News:Health News:Low Umbilical Cord pH Tied to Death, Brain Damage 2Health News:Hayes, Inc. Releases Guide to BRCA1 and BRCA2 Genetic Testing 2Health News:Hayes, Inc. Releases Guide to BRCA1 and BRCA2 Genetic Testing 3Health News:Swanson Health Products Opens East Coast Distribution Center 2Health News:Houston Weight-Loss Surgical Specialists Offer Gastric Sleeve Operation For $11K 2Health News:Houston Weight-Loss Surgical Specialists Offer Gastric Sleeve Operation For $11K 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 2Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 4Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 5Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 6Health News:Too Many Wouldn't Call 911 If Stroke Hit 2Health News:Too Many Wouldn't Call 911 If Stroke Hit 3
    ... PulseOx 7500 incorporates SPO Medical's unique ... applications, for maximum user comfort and ... power for extended usage, eliminating the ... PulseOx 7500 downloads stored readings to ...
    LOGIQ Book XP provides you the next generation performance in a compact platform....
    A patient care system tailored to your specific needs that supports current and previous-generation ICDs and pacemakers....
    ... hydrophilic PressureWire Certus guidewire from Radi ... cardiology tool for guiding intervention in ... Fractional Flow Reserve (FFR)., ,Enhanced handling ... with a strengthened core wire linking ...
    Medicine Products: